Paliperidone Palmitate
Who holds supplier records for Paliperidone Palmitate? 13 organisations hold a current record for Paliperidone Palmitate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (9), Peru (1), Belgium (1), China (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Paliperidone Palmitate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/paliperidone-palmitate
Reading the evidence
- 13 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
9 of the 13 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Paliperidone Palmitate expires 24 Nov 2041. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (13)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Paliperidone Palmitate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- INTERQUIM SAPeru Company GMP cert on recordActive DMF 32852, 29328 · latest filing Jul 2018
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 30597, 30102 · latest filing Jun 2016
- Neuland Laboratories LimitedIndiaActive DMF 26195, 32435 · latest filing Mar 2018
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 38744 · latest filing Sept 2023
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 24698 · latest filing Mar 2011
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 32041 · latest filing Oct 2017
- Janssen Pharmaceutica NVBelgium Company GMP cert on recordActive DMF 20902 · latest filing Oct 2007
- JUBILANT BIOSYS LTDIndiaActive DMF 27257 · latest filing Sept 2013
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 27787 · latest filing Dec 2013
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 32599 · latest filing Apr 2018
- Qilu Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 36497 · latest filing Dec 2021
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 38892 · latest filing Mar 2024
- TAPI NL BVNetherlandsActive DMF 41949 · latest filing Dec 2025
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (17 listed products contain Paliperidone Palmitate). The latest listed patent expires 24 Nov 2041. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Paliperidone Palmitate is a long-acting injectable atypical antipsychotic used in the treatment of schizophrenia. It is an ester of paliperidone, which is the primary active metabolite of risperidone.
Chemical identity
- IUPAC name
- [3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl] hexadecanoate
- Canonical SMILES
- CCCCCCCCCCCCCCCC(=O)OC1CCCN2C1=NC(=C(C2=O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F)C
- InChIKey
- VOMKSBFLAZZBOW-UHFFFAOYSA-N
- Synonyms
- Invega API, 9-hydroxyrisperidone palmitate, erzofri, invega sustenna, invega trinza, jns-010, jns010, paliperidone janssen, pp3m, r-092670, ro-92670, ro92670
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Atypical Antipsychotic
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Paliperidone Palmitate?
13 organisations hold an active US FDA Type II Drug Master File or a CEP for Paliperidone Palmitate: INTERQUIM SA (Peru), MATRIX PHARMACORP PRIVATE LTD (India), Neuland Laboratories Limited (India), APITORIA PHARMA PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India), GLAND PHARMA LTD (India), Janssen Pharmaceutica NV (Belgium) and JUBILANT BIOSYS LTD (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Paliperidone Palmitate Drug Master Files are active?
INTERQUIM SA (DMF 32852, 29328), MATRIX PHARMACORP PRIVATE LTD (DMF 30597, 30102), Neuland Laboratories Limited (DMF 26195, 32435), APITORIA PHARMA PRIVATE LTD (DMF 38744), Dr. Reddy's Laboratories Ltd. (DMF 24698), GLAND PHARMA LTD (DMF 32041), Janssen Pharmaceutica NV (DMF 20902) and JUBILANT BIOSYS LTD (DMF 27257) and 5 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does the FDA Orange Book list patents for products containing Paliperidone Palmitate?
Yes. The latest patent listed for an approved US product containing Paliperidone Palmitate expires 24 Nov 2041, across 17 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Paliperidone Palmitate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Paliperidone Palmitate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.